Daiwa held the “BioBran International Workshop in 2018″ in Kyoto, Japan

Daiwa was awarded with “Rising Small and Medium Enterprises 300 in 2017”

Daiwa was selected for Subsidy from the Small and Medium Enterprise Agency for the Development of a New Functional Food Material

Daiwa was selected for Subsidy from the Kanto Bureau of Economy, Trade and Industry for the Development of Functional Food Ingredient

Daiwa held the “BioBran International Workshop 2014” in Tokyo, Japan.

Daiwa obtained a patent for BioBran as an agent for bowel disease treatment.

Daiwa was selected for Subsidy from the Small and Medium Enterprise Agency for the Development of a New Functional Food Material

Daiwa was authorized as “The Project Based on Collaboration of Primary, Secondary, and Tertiary Industry Act” by the Ministry of Agriculture, Forestry and Fisheries

Daiwa held the “NKCP Workshop 2013” in Tokyo, Japan.

Global sales of BioBran spread to 50 countries.

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in USA.

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Hong Kong.

Daiwa launched “Kefira Plus”, a new product from “LK500” and “Kefira”.

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in China.

Daiwa held the “BioBran Workshop 2010” in Tokyo, Japan.

Global sales of NKCP spread to 20 countries.

Daiwa obtained a patent (cancer distant metastasis-suppressing agent) for NKCP in Japan.
Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Switzerland, Germany, France and UK.

Daiwa held the “BioBran International Workshop 2009” in Tokyo, Japan.

Daiwa obtained a patent (Diabetes drug) for NKCP in Japan.

Daiwa launched Rice Kefiran-based products, “LK500” and “Kefira”.

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Taiwan.

Global sales of BioBran spread to 40 countries.
Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Korea.

Daiwa held a meeting to launch “Rice Kefiran”, a new vegetable-origin functional food ingredient, in Tokyo, Japan.
Daiwa began export of Rice Kefiran.

Daiwa held BioBran book publication seminar in Tokyo, Japan.

Daiwa launched new BioBran-based products, “Lentin Plus LY” and “BioBran Candy”.

Daiwa established overseas affiliated company, Daiwa Health Development Inc., in Los Angeles, CA., U.S.A.

Daiwa obtained a process patent for NKCP in Japan.

Daiwa held International Seminar, “2004 General Meeting of BioBran Study Conference”, in Tokyo, Japan.
Daiwa obtained a process patent for BioBran in Japan.

Tsukuba Plant obtained HACCP certification.

Daiwa obtained approval from the Ministry of Health, Labor, and Welfare to label “PIOTEA Drink Powder” as a food for specified health use.

Daiwa established overseas affiliated company, SIAM DHD, in Bangkok, Thailand.

Daiwa completed expansion of the Tsukuba Plant.

Daiwa obtained ISO9001 certification.

Global sales of BioBran spread to 27 countries.

Daiwa began export of NKCP.

Daiwa obtained approval from the Ministry of Health, Labor, and Welfare to label “PIOTEA Drink” and “PIOTEA Roasted Powder” as a food for specified health use.
Daiwa launched a NKCP-based product, “NKCP tablet”.

Daiwa held the “BioBran Study Conference 2001” in Tsukuba, Japan.

Daiwa established overseas affiliated company, DHD (Europe) Ltd, in Cambridge, U.K.

Daiwa commenced research and development of Rice Kefiran, with sponsorship from the Ministry of Agriculture, Forestry, and Fisheries of Japan.

Daiwa opened the Tsukuba Plant.

Daiwa began export of BioBran to the United States.

Daiwa commenced research and development of Purified Natto Culture Filtrate (NKCP).

Daiwa obtained a process patent for BioBran in 8 countries, including the U.S.

Daiwa began export of BioBran to both Korea and Taiwan.

Daiwa opened the Kakegawa Plant.
Daiwa launched a BioBran-based product, “Lentin Plus 1000”.

Daiwa established the extraction technology of a new physiologically active substance, “MGN-3” (Rice Bran Arabinoxylan Compound), in rice bran.

Daiwa commenced development in the area of functional foods.
Daiwa began a cooperative study with Professor Mamdooh Ghoneum of UCLA/Drew University of Medicine and Science.

Daiwa Pharmaceutical Co., Ltd. was founded.
Daiwa began export of pharmaceuticals.